1
All patients receive recombinant human granulocyte colony-stimulating factor to minimize the risk of neutropenic fever.
2
The routine use of recombinant human granulocyte-colony stimulating factor seemed to ameliorate some of the dose-limiting toxicity of neutropenia.
3
Normal human granulocytes obtained by Ficoll-Hypaque sedimentation were subjected to mild hypotonic shock and disruption by shear.
4
The structure of the dimeric form of native S100A12 from human granulocytes in the presence of calcium in space group R3 has previously been reported.